Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00449696 · ClinicalTrials.gov registry record · Phase 3
Gel-200 Versus Placebo in Osteoarthritis of the Knee
A Phase 3 study, sponsored by Seikagaku Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 379
- Enrollment target
NCT00449696 is a Phase 3 study that has completed, run by Seikagaku Corporation. The registered enrollment target is 379 participants.
The verdict
NCT00449696, a Phase 3 study, has completed, sponsored by Seikagaku Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 379 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a single intra-articular injection of Gel-200 is superior to a single injection of Phosphate Buffered Saline (PBS) in subjects with symptomatic osteoarthritis of the knee.
Interventions
- DEVICE Placebo
- DEVICE Gel-200
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00449696
The ClinicalTrials.gov registry entry for NCT00449696 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seikagaku Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00449696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00449696 about?
NCT00449696 is a clinical study titled "Gel-200 Versus Placebo in Osteoarthritis of the Knee". The purpose of this study is to determine if a single intra-articular injection of Gel-200 is superior to a single injection of Phosphate Buffered Saline (PBS) in subjects with symptomatic osteoarthritis of the knee.
What is the current status of trial NCT00449696?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 379 participants. The study started on 2006-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00449696?
The interventions under investigation include: Placebo (DEVICE), Gel-200 (DEVICE).
Who is sponsoring clinical trial NCT00449696?
This trial is sponsored by Seikagaku Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.